A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer (Q42669118)
Jump to navigation
Jump to search
scientific article published on June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer |
scientific article published on June 2010 |
Statements
1 reference
A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer (English)
1 reference
Juergen Hennig
1 reference
Joachim Drevs
1 reference
Michael Medinger
1 reference
Klaus Mross
1 reference
Stefan Fuxius
1 reference
Martin Buechert
1 reference
Anne Thomas
1 reference
Clemens Unger
1 reference
Bee-Lian Chen
1 reference
David Lebwohl
1 reference
Dirk Laurent
1 reference
1 June 2010
1 reference
1 reference